Dr. Christopher Burch Anderson, MD

Dr. Anderson practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Anderson's NPI, 1710152186, was assigned on April 28, 2008. Dr. Anderson graduated from Feinberg School of Medicine in 2008. Dr. Anderson holds New York license 267587.

Dr. Anderson's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Anderson's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Anderson is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Anderson to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anderson practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Anderson's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Anderson is board certified in urology by the American Board of Urology. Dmand AI has Dr. Anderson's licenses on file in 2 states: New York and Florida.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, prostate cancer, prostate surgery and urinary endoscopy among the conditions Dr. Anderson treats.

CMS data shows 888 Medicare services from Dr. Anderson across 14 procedure codes in 2024, for 551 Medicare patients. Medicare paid $122,180 for them.

CMS counts 551 Medicare patients who saw Dr. Anderson in 2024. The largest group is 65 to 74, with 247 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Anderson's median patient age at 70, with 15% women.

In 2024, Dr. Anderson wrote 679 Medicare Part D claims for 225 patients. 86% of them were for generic drugs. CMS names the drug for 571 of them, across 16 drugs with 11 or more claims each, at $85,372 in total drug cost. In 2023, CMS named 424 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Anderson for performance year 2024, reported through an alternative payment model (APM). Dr. Anderson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Anderson as offering telehealth. CMS counts 13 procedures of prostate resection by Dr. Anderson, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 96 papers to Dr. Anderson, published from 2008 to 2025. 2024 was the busiest year, with 13. The most frequent topics are Urinary Bladder Neoplasms, Cystectomy and Neoplasm Invasiveness. Dr. Anderson has published most often in Urol Oncol. Dr. Anderson's most frequent co-authors are James M. McKiernan, MD, Gina M. Badalato and Guarionex Joel Decastro, MD.

CMS Open Payments shows 33 general payments to Dr. Anderson from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Photocure Inc paid the most, $369.

Dr. Anderson graduated from Feinberg School of Medicine in 2008. Dr. Anderson is a member of AUA.

Dr. Anderson is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.